Omega Healthcare Investors Hits New 52-Week High of $49.14

Omega Healthcare Investors, Inc., a small-cap player in the realty sector, has reached a significant milestone by hitting a new 52-week high of USD 49.14 on February 27, 2026. This achievement underscores the company's strong performance over the past year, with a remarkable 51.55% increase compared to the S&P 500's 17.36% gain during the same period. The stock's journey has been marked by a solid operating cash flow, which peaked at USD 836.31 million, and a return on capital employed (ROCE) of 10.47%. Additionally, Omega Healthcare has maintained a low debt-equity ratio of 84.89%, reflecting a prudent financial strategy. Despite a modest annual net sales growth rate of 2.57%, the company has consistently reported positive results for the last four consecutive quarters. With a return on equity (ROE) of 9.80% and a price-to-book value ratio of 2.28, Omega Healthcare is positioned favorably within its industry. The stock's performance has been bolstered by a 37.1% increase in profits over the past year, further enhancing its market standing.